Market Overview:
The global protease inhibitors market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for protease inhibitors in biotechnology, medicine, microbiology, and agriculture applications. In addition, the growing demand for food additives and cosmetics is also contributing to the growth of this market. North America dominates the global protease inhibitors market followed by Europe and Asia Pacific.
Product Definition:
A protease inhibitor is a molecule that inhibits the action of one or more proteases. Protease inhibitors are used in medicine to treat diseases in which proteases play a role, such as AIDS and cancer.
Reagent Grade:
Reagent grade is a high purity form of the product that has been purified and characterized by using an adsorption process. It's major application includes use in protease inhibitors drug development. The growth factor for this market is expected to be its increasing demand in research laboratories due to rising R&D activities related to pharmaceuticals & biotechnology industry.
Pharmaceutical:
Pharmaceutical is the branch of science that studies chemical substances and their interactions with biological systems. Pharmaceuticals are used to treat diseases and disorders. They can be used as drugs, medicines or vaccines depending on what they are being studied for. Pharmaceutical products can be classified on the basis of various factors such as their use (therapeutic, diagnostic), route of administration, type of molecule etc.
Application Insights:
The biotechnology segment dominated the global protease inhibitors market in 2017 and is expected to witness significant growth over the forecast period. The increasing demand for enzymes-based drugs to develop treatments for chronic diseases such as cancer, Alzheimer¢â‚¬â„¢s disease, and cardiovascular disorders is projected to boost industry growth.
Protease enzymes are used in various applications including medicine, food additives, cosmetics & personal care products manufacturing and agriculture. In medicine application accounted for 33% of total market revenue share in 2017 owing to its wide usage across cancer treatment which includes chemotherapy and radiation therapy as well as being used alone or in combination with other drugs for the treatment of different types of cancers such as lung cancer, liver cancer etc.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a well-established biotechnology, pharmaceuticals and food processing & additive industries. The region is expected to maintain its dominance over the forecast period due to factors such as favorable government policies and increasing R&D expenditure by companies. Asia Pacific is projected to grow at a lucrative rate during the forecast period owing to rising healthcare spending by countries such as China, India, Japan and South Korea. In addition, growing awareness regarding protease inhibitors among medical practitioners in emerging economies of this region will drive growth further.
Growth Factors:
- Increasing incidence of chronic diseases such as cancer, diabetes, and AIDS is expected to drive the demand for protease inhibitors over the forecast period.
- Growing awareness about protease inhibitors and their benefits is projected to boost the market growth.
- The increasing use of protease inhibitors in combination therapies is anticipated to fuel the market growth during the forecast period.
- Rising number of clinical trials for new drugs is likely to propel the demand for protease inhibitors in coming years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Protease Inhibitors Market Research Report
By Type
Reagent Grade, Pharmaceutical, Others
By Application
Biotechnology, Medicine, Microbiology, Agriculture, Pharmaceuticals, Food Additives, Cosmetics
By Companies
CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), China Biologic Products, Inc. (China), Biotest AG (Germany), LFB S.A (France), Bio Product Laboratory Ltd. (U.K.), Sanquin (Netherlands)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Protease Inhibitors Market Report Segments:
The global Protease Inhibitors market is segmented on the basis of:
Types
Reagent Grade, Pharmaceutical, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology, Medicine, Microbiology, Agriculture, Pharmaceuticals, Food Additives, Cosmetics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CSL Ltd. (Australia)
- Grifols S.A (Spain)
- Baxalta Incorporated (U.S.)
- Octapharma AG (Switzerland)
- Kedrion S.p.A (Italy)
- China Biologic Products, Inc. (China)
- Biotest AG (Germany)
- LFB S.A (France)
- Bio Product Laboratory Ltd. (U.K.)
- Sanquin (Netherlands)
Highlights of The Protease Inhibitors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reagent Grade
- Pharmaceutical
- Others
- By Application:
- Biotechnology
- Medicine
- Microbiology
- Agriculture
- Pharmaceuticals
- Food Additives
- Cosmetics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Protease Inhibitors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Protease inhibitors are medications that block the action of proteases, which are enzymes that break down proteins. Protease inhibitors can be used to treat a variety of conditions, including HIV/AIDS and cancer.
Some of the key players operating in the protease inhibitors market are CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), China Biologic Products, Inc. (China), Biotest AG (Germany), LFB S.A (France), Bio Product Laboratory Ltd. (U.K.), Sanquin (Netherlands).
The protease inhibitors market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Protease Inhibitors Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Protease Inhibitors Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Protease Inhibitors Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Protease Inhibitors Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Protease Inhibitors Market Size & Forecast, 2018-2028
4.5.1 Protease Inhibitors Market Size and Y-o-Y Growth
4.5.2 Protease Inhibitors Market Absolute $ Opportunity
Chapter 5 Global Protease Inhibitors Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Protease Inhibitors Market Size Forecast by Type
5.2.1 Reagent Grade
5.2.2 Pharmaceutical
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Protease Inhibitors Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Protease Inhibitors Market Size Forecast by Applications
6.2.1 Biotechnology
6.2.2 Medicine
6.2.3 Microbiology
6.2.4 Agriculture
6.2.5 Pharmaceuticals
6.2.6 Food Additives
6.2.7 Cosmetics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Protease Inhibitors Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Protease Inhibitors Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Protease Inhibitors Analysis and Forecast
9.1 Introduction
9.2 North America Protease Inhibitors Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Protease Inhibitors Market Size Forecast by Type
9.6.1 Reagent Grade
9.6.2 Pharmaceutical
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Protease Inhibitors Market Size Forecast by Applications
9.10.1 Biotechnology
9.10.2 Medicine
9.10.3 Microbiology
9.10.4 Agriculture
9.10.5 Pharmaceuticals
9.10.6 Food Additives
9.10.7 Cosmetics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Protease Inhibitors Analysis and Forecast
10.1 Introduction
10.2 Europe Protease Inhibitors Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Protease Inhibitors Market Size Forecast by Type
10.6.1 Reagent Grade
10.6.2 Pharmaceutical
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Protease Inhibitors Market Size Forecast by Applications
10.10.1 Biotechnology
10.10.2 Medicine
10.10.3 Microbiology
10.10.4 Agriculture
10.10.5 Pharmaceuticals
10.10.6 Food Additives
10.10.7 Cosmetics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Protease Inhibitors Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Protease Inhibitors Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Protease Inhibitors Market Size Forecast by Type
11.6.1 Reagent Grade
11.6.2 Pharmaceutical
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Protease Inhibitors Market Size Forecast by Applications
11.10.1 Biotechnology
11.10.2 Medicine
11.10.3 Microbiology
11.10.4 Agriculture
11.10.5 Pharmaceuticals
11.10.6 Food Additives
11.10.7 Cosmetics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Protease Inhibitors Analysis and Forecast
12.1 Introduction
12.2 Latin America Protease Inhibitors Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Protease Inhibitors Market Size Forecast by Type
12.6.1 Reagent Grade
12.6.2 Pharmaceutical
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Protease Inhibitors Market Size Forecast by Applications
12.10.1 Biotechnology
12.10.2 Medicine
12.10.3 Microbiology
12.10.4 Agriculture
12.10.5 Pharmaceuticals
12.10.6 Food Additives
12.10.7 Cosmetics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Protease Inhibitors Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Protease Inhibitors Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Protease Inhibitors Market Size Forecast by Type
13.6.1 Reagent Grade
13.6.2 Pharmaceutical
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Protease Inhibitors Market Size Forecast by Applications
13.10.1 Biotechnology
13.10.2 Medicine
13.10.3 Microbiology
13.10.4 Agriculture
13.10.5 Pharmaceuticals
13.10.6 Food Additives
13.10.7 Cosmetics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Protease Inhibitors Market: Competitive Dashboard
14.2 Global Protease Inhibitors Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CSL Ltd. (Australia)
14.3.2 Grifols S.A (Spain)
14.3.3 Baxalta Incorporated (U.S.)
14.3.4 Octapharma AG (Switzerland)
14.3.5 Kedrion S.p.A (Italy)
14.3.6 China Biologic Products, Inc. (China)
14.3.7 Biotest AG (Germany)
14.3.8 LFB S.A (France)
14.3.9 Bio Product Laboratory Ltd. (U.K.)
14.3.10 Sanquin (Netherlands)
